Results 291 to 300 of about 168,526 (308)

Aldosterone-to-Renin Ratio Changes in Patients With Renal Artery Stenosis and Aldosteronism. [PDF]

J Clin Hypertens (Greenwich)
Wang Q, Dong H, Li H, Zuo Y, Zou Y, Jiang X.   +5 more
europepmc   +1 more source

Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano, Suguru Okami, Hiroshi Kanegae, Nikolaus G. Oberprieler, Catherine Johannes, Satoshi Yamashita, Kanae Yoshikawa‐Ryan, Csaba P. Kovesdy, David Vizcaya, Naoki Kashihara   +9 more
wiley   +1 more source

Measurement accuracy and cutoffs for predicting primary aldosteronism diagnosis using Lumipulse® for renin and aldosterone measurements. [PDF]

PLoS One
Laney M, Nabi-Bourgois A, Mallart-Riancho J, Travers S, Chebbi M, Kling A, Amar L, Baron S.   +7 more
europepmc   +1 more source

Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We assessed the effects of dapagliflozin on natriuresis and blood pressure in patients with type 2 diabetes and chronic kidney disease (CKD) and evaluated the consistency of these effects across patients with type 2 diabetes without CKD and CKD without type 2 diabetes.
Jelle M. Beernink, Niels Jongs, Charlotte M. Mosterd, Rosalie A. Scholtes, Alyssa Caldwell‐McGee, Daniel Casillas, Lynette Driscoll, Peter J. Greasley, Cecilia Karlsson, Ann Hammarstedt, Vikas S. Sridhar, Marcel H. A. Muskiet, Gozewijn D. Laverman, David Z. I. Cherney, Petter Bjornstad, Daniel H. van Raalte, Hiddo J. L. Heerspink   +16 more
wiley   +1 more source

The triglyceride glucose (TyG) index is associated with decreased myocardial mechano‐energetic efficiency in individuals with different glucose tolerance status

European Journal of Clinical Investigation, Volume 55, Issue 6, June 2025.
A higher TyG index can identify individuals at increased cardiovascular risk. Abstract Background This investigation had two main objectives: (1) to compare the triglyceride–glucose (TyG) index with the homeostasis model assessment of insulin resistance (HOMA‐IR) in relation to insulin‐stimulated myocardial glucose metabolic rate (MrGlu), measured by a
Chiara M. A. Cefalo, Alessia Riccio, Teresa Vanessa Fiorentino, Elena Succurro, Maria Perticone, Velia Cassano, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti   +8 more
wiley   +1 more source

Severe headache as a key symptom in bilateral idiopathic adrenal hyperplasia-induced primary hyperaldosteronism: A case report. [PDF]

Medicine (Baltimore)
Abduljabbar AS, Hashim HT, Al-Obaidi AD, Basalilah AFM, Al-Gburi I, Madhi ZSA.   +5 more
europepmc   +1 more source

Right ventricular strain and tricuspid annular plane systolic excursion are associated with mortality in inferior ST‐elevation myocardial infarction

European Journal of Clinical Investigation, Volume 55, Issue 6, June 2025.
The right ventricular longitudinal strain, right ventricular free wall strain and the tricuspid annular plane systolic excursion are associated with all‐cause mortality in patients with acute inferior ST‐segment elevation myocardial infarction.
Michael Poledniczek, Andreas Kammerlander, Caroline Jansen, Daniel Feser, Severin Ehrengruber, Eva Steinacher, Christian Hengstenberg, Alexander Niessner, Irene Lang, Thomas Binder, Bernhard Richter   +10 more
wiley   +1 more source

Non-Hypertensive Effects of Aldosterone. [PDF]

Int J Mol Sci
Ekman N, Grossman AB, Nieckarz A, Jędrzejewski Ł, Wolf J, Dworakowska D.   +5 more
europepmc   +1 more source

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation

European Journal of Clinical Investigation, EarlyView.
This consensus highlights critical research gaps in obesity epidemiology, phenotypic heterogeneity and clinical management, calling for advanced methodologies, collaborative strategies and innovative policies to mitigate the global obesity epidemic and its socio‐economic impacts.
Federico Carbone, Jean‐Pierre Després, John P. A. Ioannidis, Ian J. Neeland, Gabriella Garruti, Luca Busetto, Luca Liberale, Stefano Ministrini, Gemma Vilahur, Thomas H. Schindler, Maria Paula Macedo, Agostino Di Ciaula, Marcin Krawczyk, Andreas Geier, Gyorgy Baffy, Maria Felicia Faienza, Ilaria Farella, Nicola Santoro, Gema Frühbeck, Patricia Yárnoz‐Esquiroz, Javier Gómez‐Ambrosi, Emma Chávez‐Manzanera, Verónica Vázquez‐Velázquez, Jean‐Michel Oppert, Dimitrios N. Kiortsis, Paolo Sbraccia, Carmine Zoccali, Piero Portincasa, Fabrizio Montecucco   +28 more
wiley   +1 more source

MicroRNA-34a Mediates the Aldosterone-Induced Acceleration of Endothelial Senescence. [PDF]

Int J Hypertens
Jia M, Lin L, Yang B, Yu H, Zhong S, Xu X, Song X.   +6 more
europepmc   +1 more source